Evidence map›Paper›PMID 38004523›Full record

ArticlePharmaceutics2023

A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.

Niklas Köhler, Hande Karaköse, Hans-Peter Grobbel, Doris Hillemann, Sönke Andres, Christina König, Barbara Kalsdorf, Thomas Theo Brehm, Laura Böttcher, Inna Friesen and 11 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Identification ofInfection and drug resistance · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 4 countries.

Niklas KöhlerClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.ORCID 0000-0002-1911-0379
Hande KaraköseGerman Center for Infection Research (DZIF), Partner Site Borstel-Hamburg-Lübeck-Riems, 23845 Borstel, Germany.
Hans-Peter GrobbelClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.ORCID 0000-0002-1467-1273
Doris HillemannNational and World Health Organization Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, 23845 Borstel, Germany.
Sönke AndresNational and World Health Organization Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, 23845 Borstel, Germany.
Christina KönigDepartment of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Barbara KalsdorfClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.
Thomas Theo BrehmDivision of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0003-1737-161X
Laura BöttcherClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.
Inna FriesenNational and World Health Organization Supranational Reference Laboratory for Mycobacteria, Research Center Borstel, 23845 Borstel, Germany.
Harald HoffmannInstitute of Microbiology and Laboratory Medicine, World Health Organization Supranational Reference Laboratory of TB, IML red GmbH, 82131 Gauting, Germany.
Dražen StrelecDepartment for Lung Diseases, Hospital for Lung Diseases and Tuberculosis, 42244 Klenovnik, Croatia.
Dagmar SchaubClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.
Charles A PeloquinInfectious Disease Pharmacokinetics Laboratory, Emerging Pathogens Institute, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0001-9002-7052
Stefan SchmiedelDivision of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Laurent A DecosterdLaboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
Eva ChoongLaboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0001-6776-4978
Sebastian G WichaInstitute of Pharmacy, University of Hamburg, 20246 Hamburg, Germany.
Rob E AarnoutseDepartment of Pharmacy, Radboud Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Christoph LangeClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.ORCID 0000-0002-9691-4741
Patricia M Sánchez CarballoClinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany.ORCID 0000-0003-1061-7023
German Center for Infection Research · DEUniversität Hamburg · DEUniversity of Lausanne · CHBaylor College of Medicine · USRadboud University Nijmegen · NLSynlab (Germany) · DEUniversity of Florida · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

The treatment of drug-resistant

Indexed as

bedaquilineclofaziminecycloserinedelamanidlevofloxacinlinezolidmeropenemmoxifloxacinTDMterizidone

Identifiers

PMID38004523
PMCPMC10674734
OpenAlexW4387975858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.